A run on the biobank: What have we learned about type 1 diabetes from the nPOD tissue repository?

John S. Kaddis, Alberto Pugliese, Mark A. Atkinson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose of review Since the inaugural year of its biobank in 2007, the Network for Pancreatic Organ Donors with Diabetes program has provided 70370 human samples to 127 investigators worldwide for projects focused on the pathogenesis of type 1 diabetes (T1D). The purpose of this review was to highlight major advances in our understanding of T1D using works that contain original data from experiments utilizing biospecimens provided by the Network for Pancreatic Organ Donors with Diabetes program. A total of 15 studies, published between 1 June 2013 and 31 December 2014, were selected using various search and filter strategies. Recent findings The type and frequency of B and/or T-cell immune markers in both the endocrine and exocrine compartments vary in T1D. Enterovirus signals have been identified as having new proteins in the extracellular matrix around infiltrated islets. Novel genes within human islet cell types have been shown to play a role in immunity, infiltration, inflammation, disease progression, cell mass and function. Various cytokines and a complement degradation product have also been detected in the blood or surrounding pancreatic ducts/vasculature. Summary These findings, from T1D donors across the disease spectrum, emphasize the notion that pathogenic heterogeneity is a hallmark of the disorder.

Original languageEnglish (US)
Pages (from-to)290-295
Number of pages6
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Volume22
Issue number4
DOIs
StatePublished - Aug 23 2015

Fingerprint

Type 1 Diabetes Mellitus
Tissue Donors
Enterovirus
Extracellular Matrix Proteins
Pancreatic Ducts
Islets of Langerhans
Disease Progression
Immunity
Biomarkers
Research Personnel
Cytokines
Inflammation
T-Lymphocytes
Genes

Keywords

  • atrophy
  • immunity
  • infiltration
  • pancreas
  • regeneration

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Cite this

A run on the biobank : What have we learned about type 1 diabetes from the nPOD tissue repository? / Kaddis, John S.; Pugliese, Alberto; Atkinson, Mark A.

In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 22, No. 4, 23.08.2015, p. 290-295.

Research output: Contribution to journalArticle

@article{35190559187647eca6024148a79c043a,
title = "A run on the biobank: What have we learned about type 1 diabetes from the nPOD tissue repository?",
abstract = "Purpose of review Since the inaugural year of its biobank in 2007, the Network for Pancreatic Organ Donors with Diabetes program has provided 70370 human samples to 127 investigators worldwide for projects focused on the pathogenesis of type 1 diabetes (T1D). The purpose of this review was to highlight major advances in our understanding of T1D using works that contain original data from experiments utilizing biospecimens provided by the Network for Pancreatic Organ Donors with Diabetes program. A total of 15 studies, published between 1 June 2013 and 31 December 2014, were selected using various search and filter strategies. Recent findings The type and frequency of B and/or T-cell immune markers in both the endocrine and exocrine compartments vary in T1D. Enterovirus signals have been identified as having new proteins in the extracellular matrix around infiltrated islets. Novel genes within human islet cell types have been shown to play a role in immunity, infiltration, inflammation, disease progression, cell mass and function. Various cytokines and a complement degradation product have also been detected in the blood or surrounding pancreatic ducts/vasculature. Summary These findings, from T1D donors across the disease spectrum, emphasize the notion that pathogenic heterogeneity is a hallmark of the disorder.",
keywords = "atrophy, immunity, infiltration, pancreas, regeneration",
author = "Kaddis, {John S.} and Alberto Pugliese and Atkinson, {Mark A.}",
year = "2015",
month = "8",
day = "23",
doi = "10.1097/MED.0000000000000171",
language = "English (US)",
volume = "22",
pages = "290--295",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - A run on the biobank

T2 - What have we learned about type 1 diabetes from the nPOD tissue repository?

AU - Kaddis, John S.

AU - Pugliese, Alberto

AU - Atkinson, Mark A.

PY - 2015/8/23

Y1 - 2015/8/23

N2 - Purpose of review Since the inaugural year of its biobank in 2007, the Network for Pancreatic Organ Donors with Diabetes program has provided 70370 human samples to 127 investigators worldwide for projects focused on the pathogenesis of type 1 diabetes (T1D). The purpose of this review was to highlight major advances in our understanding of T1D using works that contain original data from experiments utilizing biospecimens provided by the Network for Pancreatic Organ Donors with Diabetes program. A total of 15 studies, published between 1 June 2013 and 31 December 2014, were selected using various search and filter strategies. Recent findings The type and frequency of B and/or T-cell immune markers in both the endocrine and exocrine compartments vary in T1D. Enterovirus signals have been identified as having new proteins in the extracellular matrix around infiltrated islets. Novel genes within human islet cell types have been shown to play a role in immunity, infiltration, inflammation, disease progression, cell mass and function. Various cytokines and a complement degradation product have also been detected in the blood or surrounding pancreatic ducts/vasculature. Summary These findings, from T1D donors across the disease spectrum, emphasize the notion that pathogenic heterogeneity is a hallmark of the disorder.

AB - Purpose of review Since the inaugural year of its biobank in 2007, the Network for Pancreatic Organ Donors with Diabetes program has provided 70370 human samples to 127 investigators worldwide for projects focused on the pathogenesis of type 1 diabetes (T1D). The purpose of this review was to highlight major advances in our understanding of T1D using works that contain original data from experiments utilizing biospecimens provided by the Network for Pancreatic Organ Donors with Diabetes program. A total of 15 studies, published between 1 June 2013 and 31 December 2014, were selected using various search and filter strategies. Recent findings The type and frequency of B and/or T-cell immune markers in both the endocrine and exocrine compartments vary in T1D. Enterovirus signals have been identified as having new proteins in the extracellular matrix around infiltrated islets. Novel genes within human islet cell types have been shown to play a role in immunity, infiltration, inflammation, disease progression, cell mass and function. Various cytokines and a complement degradation product have also been detected in the blood or surrounding pancreatic ducts/vasculature. Summary These findings, from T1D donors across the disease spectrum, emphasize the notion that pathogenic heterogeneity is a hallmark of the disorder.

KW - atrophy

KW - immunity

KW - infiltration

KW - pancreas

KW - regeneration

UR - http://www.scopus.com/inward/record.url?scp=84937797996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937797996&partnerID=8YFLogxK

U2 - 10.1097/MED.0000000000000171

DO - 10.1097/MED.0000000000000171

M3 - Article

C2 - 26087339

AN - SCOPUS:84937797996

VL - 22

SP - 290

EP - 295

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 4

ER -